Skip to content
healthcare.dev
Get a free key

Bioplasma

NDC 54973-4086, SILICON DIOXIDE,POTASSIUM CHLORIDE,SODIUM SULFATE,FERROSOFERRIC PHOSPHATE,MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE,SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE,TRIBASIC CALCIUM PHOSPHATE,POTASSIUM PHOSPHATE, DIBASIC,POTASSIUM SULFATE,SODIUM CHLORIDE,CALCIUM SULFATE ANHYDROUS,CALCIUM FLUORIDE, tablet, soluble, from Hyland's Inc..

Product NDC
54973-4086
Status
Listed
Labeler
Hyland's Inc.
Dosage form
TABLET, SOLUBLE
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
UNAPPROVED HOMEOPATHIC
Application
—
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/54973-4086 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • SILICON DIOXIDE6 [hp_X]/1
  • TRIBASIC CALCIUM PHOSPHATE3 [hp_X]/1
  • FERROSOFERRIC PHOSPHATE3 [hp_X]/1
  • MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE3 [hp_X]/1
  • SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE3 [hp_X]/1
  • POTASSIUM CHLORIDE3 [hp_X]/1
  • POTASSIUM PHOSPHATE, DIBASIC3 [hp_X]/1
  • POTASSIUM SULFATE3 [hp_X]/1
  • SODIUM CHLORIDE6 [hp_X]/1
  • CALCIUM SULFATE ANHYDROUS3 [hp_X]/1
  • CALCIUM FLUORIDE6 [hp_X]/1
  • SODIUM SULFATE3 [hp_X]/1

Pharmacologic classes

Blood Coagulation Factor [EPC]; Calcium [CS]; Calculi Dissolution Agent [EPC]; Cations, Divalent [CS]; Increased Coagulation Factor Activity [PE]; Increased Large Intestinal Motility [PE]; Increased Large Intestinal Motility [PE]; Increased Large Intestinal Motility [PE]; Increased Large Intestinal Motility [PE]; Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]; Magnesium Ion Exchange Activity [MoA]; Osmotic Activity [MoA]; Osmotic Activity [MoA]; Osmotic Activity [MoA]; Osmotic Activity [MoA]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Osmotic Laxative [EPC]; Osmotic Laxative [EPC]; Osmotic Laxative [EPC]; Osmotic Laxative [EPC]; Phosphate Binder [EPC]; Phosphate Chelating Activity [MoA]; Potassium Compounds [CS]; Potassium Salt [EPC]; Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]

Package NDCNDC-11Package
54973-4086-1549734086011 BOTTLE, PLASTIC in 1 CARTON (54973-4086-1) / 100 TABLET, SOLUBLE in 1 BOTTLE, PLASTIC

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 54973-4086 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/54973-4086 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 54973-4086. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.